|
|
Article: Sirion Therapeutics to merge with Sytera.(biopharmaceutical firm )(Brief article)
- Article from:
- Pharma Marketletter
- Article date:
- August 21, 2006
CopyrightCOPYRIGHT 2006 Marketletter Publications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Ophthalmics specialist Sirion Therapeutics has completed a merger with fellow USA-based Sytera, a biopharmaceutical firm based in La Jolla, California, discovering new treatments for dry age-related macular degeneration. The financial terms were not disclosed, however, Sytera shareholders will be entitled to merger consideration in the form of stock and cash up front, as well as ...
Related newspaper, magazine, and journal articles:
|
|
Article: Sirion Therapeutics Acquires U.S. License to ...
PR Newswire;
January 17, 2007 ;
700+ words
... ... Jan. 17 /PRNewswire/ -- Sirion Therapeutics, Inc., an ophthalmic-focused ... Foster serves as a member of the Sirion Therapeutics, Inc. Scientific Advisory Board ... end of calendar year 2007. About Sirion Therapeutics, Inc. and Sirion Holdings, Inc ...
|
|